Publication | Open Access
HHLA2 deficiency inhibits non‐small cell lung cancer progression and THP‐1 macrophage M2 polarization
53
Citations
27
References
2021
Year
HHLA2 downregulation inhibited NSCLC growth and TAM M2 polarization. HHLA2 may serve as a therapeutic target and promising prognostic biomarker in NSCLC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1